NCT01678534View on ClinicalTrials.gov

Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions

Ischemic Stroke

Interventions

DRUG

Allogenic mesenchymal stem cells from adipose tissue

DRUG

Placebo

Trial Locations (1)

28046

University Hospital La Paz, Madrid

All Listed Sponsors

lead

Instituto de Investigación Hospital Universitario La Paz

OTHER

NCT01678534 - Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial | Biotech Hunter | Biotech Hunter